[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Andrade et al., 2015 - Google Patents

Phenotypes of severe asthma among children and adolescents in Brazil: a prospective study

Andrade et al., 2015

View HTML @Full View
Document ID
16146890486447829555
Author
Andrade W
Lasmar L
Ricci C
Camargos P
Cruz �
Publication year
Publication venue
BMC Pulmonary Medicine

External Links

Snippet

Background The morbidity associated with severe uncontrolled asthma is disproportionately higher in low-and middle-income countries than in high-income countries. The aim of this study was to describe the phenotypic characteristics of difficult-to-treat severe asthma and …
Continue reading at link.springer.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10—Services
    • G06Q50/22—Health care, e.g. hospitals; Social work
    • G06Q50/24—Patient record management
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/345—Medical expert systems, neural networks or other automated diagnosis
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references

Similar Documents

Publication Publication Date Title
Schleich et al. Real‐world experience with mepolizumab: Does it deliver what it has promised?
Andrade et al. Phenotypes of severe asthma among children and adolescents in Brazil: a prospective study
Horak et al. Diagnosis and management of asthma–Statement on the 2015 GINA Guidelines
Bateman et al. Development and validation of a novel risk score for asthma exacerbations: the risk score for exacerbations
Lommatzsch et al. Severe asthma: definition, diagnosis and treatment
Bobolea et al. Sputum periostin in patients with different severe asthma phenotypes
Kowalski et al. Clinical and immunological determinants of severe/refractory asthma (SRA): association with Staphylococcal superantigen‐specific IgE antibodies
Kupczyk et al. US and European severe asthma cohorts: what can they teach us about severe asthma?
Thomson et al. Clinical outcomes and inflammatory biomarkers in current smokers and exsmokers with severe asthma
Demoly et al. Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis
Price et al. Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care
Westerhof et al. Predictors for the development of progressive severity in new-onset adult asthma
Alpaydin et al. Asthma control test and asthma quality of life questionnaire association in adults
Gibeon et al. The investigation of severe asthma to define phenotypes
Chogtu et al. Evaluation of relationship of inhaler technique with asthma control and quality of life
Korn et al. The German severe asthma patient: baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control
Darawshy et al. Residual symptoms, lung function, and imaging findings in patients recovering from SARS-CoV-2 infection
Yilmaz et al. Children with chronic nonspecific isolated cough
Siddiqui et al. Advances in the management of severe asthma
Umoh et al. Asthma control among patients in Uyo South-Eastern Nigeria
Castillo et al. Chronic rhinosinusitis with nasal polyps and allergic rhinitis as different multimorbid treatable traits in asthma
Axelsson et al. Personality and unachieved treatment goals related to poor adherence to asthma medication in a newly developed adherence questionnaire–a population-based study
Fainardi et al. An approach to the management of children with problematic severe asthma
Portel et al. FASE-CPHG study: a panoramic snapshot of difficult-to-treat, severe asthma in French nonacademic hospitals
Demoly et al. A pragmatic primary practice approach to using specific IgE in allergy testing in asthma diagnosis, management, and referral